Guardian Pharmacy Services Announces Director Changes & Compensation Updates
Ticker: GRDN · Form: 8-K · Filed: Feb 11, 2025 · CIK: 1802255
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
Guardian Pharmacy Services is shuffling its board and tweaking exec pay.
AI Summary
Guardian Pharmacy Services, Inc. announced on February 5, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain directors and the election of new ones, alongside updates to the compensatory arrangements for its officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes and compensation adjustments, which typically carry low immediate risk.
Key Players & Entities
- Guardian Pharmacy Services, Inc. (company) — Registrant
- February 5, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Atlanta, Georgia (location) — Principal executive offices
FAQ
What specific reasons were given for the departure of directors?
The filing indicates "Departure of Directors or Certain Officers" as an item, but does not provide specific reasons for any individual departures within the provided text.
Who are the newly elected directors?
The filing lists "Election of Directors" as an item, but the names of the newly elected directors are not specified in the provided text.
What are the details of the updated compensatory arrangements?
The filing mentions "Compensatory Arrangements of Certain Officers" as an item, but the specific details of these arrangements are not included in the provided text.
When was Guardian Pharmacy Services, Inc. incorporated?
Guardian Pharmacy Services, Inc. was incorporated in Delaware, as stated in the filing.
What is the principal business address of Guardian Pharmacy Services, Inc.?
The principal business address is 300 Galleria Parkway SE, Suite 800, Atlanta, Georgia 30339.
Filing Stats: 642 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2025-02-11 16:30:28
Key Financial Figures
- $0.001 — stered Class A Common Stock, par value $0.001 per share GRDN New York Stock Excha
- $240,000 — tock units having a grant date value of $240,000 was made to each of David Morris, the C
- $270,000 — he executive officers in the amounts of $270,000 to Mr. Burke, $240,000 to Mr. Morris an
Filing Documents
- d883749d8k.htm (8-K) — 24KB
- 0001193125-25-024341.txt ( ) — 148KB
- grdn-20250205.xsd (EX-101.SCH) — 3KB
- grdn-20250205_lab.xml (EX-101.LAB) — 18KB
- grdn-20250205_pre.xml (EX-101.PRE) — 11KB
- d883749d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Guardian Pharmacy Services, Inc. February 11, 2025 By: /s/ David K. Morris Name: David K. Morris Title: Executive Vice President and Chief Financial Officer